GLP-1-hoitoihin liittyvä pahoinvointi: syyt ja toimenpiteet

Nausea is the most commonly reported side effect of GLP-1 medications. Whether you are using Ozempic, Wegovy, Saxenda, or Mounjaro, many people experience this digestive issue during the first few weeks of treatment. This article explains why this happens, how long symptoms may last, and which dietary and lifestyle changes can help.

Why do GLP-1 medications cause nausea?

GLP-1 agonists work by activating GLP-1 receptors in the digestive tract and the brain. One of their effects is slowing down gastric emptying: food stays in the stomach longer, which makes you feel full faster and encourages you to eat less. While this slowing effect is beneficial for weight loss, it is also a direct cause of nausea, bloating, and sometimes vomiting. Your body interprets this delayed gastric emptying as a sign that something is wrong, especially in the beginning, before it has adjusted to the medication's effects.

The STEP 1 study revealed that nausea was associated with the use of 2.4 mg of semaglutide in over 44 percent of participants. The good news is that as clinical studies show, only 4.5% of patients discontinued treatment due to gastrointestinal symptoms. For most patients, symptoms are mild to moderate and clearly subside as treatment progresses.

When is nausea at its worst?

Nausea usually occurs in the first few days or even weeks after increasing your dose. For semaglutide and tirzepatide, which are administered once a week, the day after the injection can be slightly more difficult. With liraglutide (Saxenda), which is taken daily, symptoms are more constant, but you also adjust to them more quickly. Once the dose stabilizes and your body gets used to the medication, nausea decreases significantly for most patients.

It is no coincidence that the dosing schedules for GLP-1-based medications are designed to be gradual. By increasing the dose slowly, your body has time to adapt. More information on this approach can be found on Goodweigh's Wegovy page. However, if nausea persists, ask your doctor if it would be sensible to extend the interval between dose increases.

What can you eat to alleviate nausea?

Your diet has a major impact on your well-being during treatment. Fatty, heavy, or very spicy meals slow down gastric emptying even further, which increases the risk of nausea. It is better to eat small, light meals throughout the day rather than three large ones. Eat slowly, chew your food thoroughly, and stop as soon as you feel full, even if the portion is smaller than usual.

A consensus statement prepared by international experts emphasizes that practical adjustments to diet and lifestyle can significantly reduce nausea associated with GLP-1 treatments. In practice, it is helpful to favor easily digestible foods: steamed vegetables, rice, soup, and cooked meat. Avoid carbonated drinks, alcohol, and rapidly absorbed sugars during the first weeks of treatment or immediately after increasing your dose. For more information on what works well with GLP-1 treatments, see the article on what to eat when using GLP-1 medications.

When should you contact a doctor?

Mild nausea is a normal and expected side effect of treatment. However, there are situations where you must contact a doctor. This applies if your nausea is so severe that you can no longer eat or drink, if vomiting continues for several days, if you have symptoms of dehydration such as dry mouth, decreased urination, or dizziness, or if you have severe abdominal pain in the upper stomach or back. The latter symptom can be a sign of acute pancreatitis, which is a rare but serious side effect that can occur with all GLP-1 medications.

Recent research on nausea as a side effect of GLP-1 medications confirms that side effects are very manageable for most users and subside as treatment progresses, but medical supervision remains essential if more serious symptoms occur. At Goodweigh, you can always contact your treating physician if you experience any side effects.

Does nausea vary by medication?

All GLP-1-based medications have a similar profile of gastrointestinal side effects, but there are differences. Liraglutide (Saxenda) has a shorter half-life and is administered daily, which means you adapt to it faster, but also that you may feel a new injection-related peak each day. Semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) are administered as weekly injections and have longer half-lives, resulting in a more consistent effect, though the transition during dose increases can feel slightly more intense.

In addition to the GLP-1 receptor, tirzepatide also activates the GIP receptor. In the SURMOUNT studies, the gastrointestinal side effect profile of tirzepatide was comparable to that of semaglutide at similar levels of weight loss, with nausea and diarrhea being the most common side effects. You can find an overview of all available medications on Goodweigh’s “Weight loss medications” page.

Nausea: a symptom, not a reason to stop treatment

Nausea associated with GLP-1 medications is unpleasant, but it is also a sign that the treatment is working. Your body is adjusting to a new metabolic state. For most patients, nausea disappears after a few weeks, especially if the dose remains stable. Don’t let the first few weeks discourage you: the effectiveness of the treatment in achieving significant weight loss has been proven, and for most patients, the side effects are temporary.

If you are wondering whether GLP-1 medication is right for you, or if you want to know if you are eligible for treatment, check out our summary article on the eligibility criteria for GLP-1 medications. You can also book your first consultation directly through the Goodweigh service, during which a doctor will assess your situation and create a personalized treatment plan for you.

‍